Something went wrong with the connection!

Trichy Daily

Global Respiratory Drugs Market to Reach US$41.3 bn by 2023

Global Respiratory Drugs Market to Reach US$41.3 bn by 2023

October 24
15:12 2017

The report offers a comprehensive assessment of this market, focusing especially on the driving forces, restraining factors, opportunities, and the dynamic competitive landscape of this market. It also analyzes the most prominent market trends and the current and historical performance of this market to determine its status in the near future

As per the estimations of this research study, the opportunity in the worldwide respiratory drugs market, which was US$30.9 bn in 2016 is anticipated to rise at a CAGR of 4.23% and reach a value of US$41.3 bn by the end of 2023. The report emphasizes on the prominent therapy area indications of chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis (CF), and idiopathic pulmonary fibrosis (IPF). The reason behind respiratory disorders among humans vary considerably across each of the indications with factors, such as occupation, genetic predisposition environment, and aging, influencing them, notes the research study.

Click to get sample PDF with TOC:

Conventionally, small molecule therapies, which aims at treating the symptoms of the disease, rather than the original cause, have been the dominating treatment for respiratory disorders. This point towards that the treatment options can be dissimilar in terms of their mechanisms of action (MoA) and targets. However, the treatment of respiratory disorders has advanced significantly over the past decade, with innovative targeted therapies making their way into the global market. The approval of the blockbuster drugs, Kalydeco (2012) and Orkambi (2014), has provided the patients and medical professionals with disease-modifying treatment options for cystic fibrosis. Targeted therapies, such as Nucala and omalizumab, have also been introduced for the treatment of asthma in the global market.

On the whole, 937 products are in the active development stage in the respiratory disorder therapeutic pipeline. The therapeutic pipelines of COPD, asthma, CF, and IPF contain 106, 261, 131, and 79 drugs, respectively. Even though the respiratory disorder therapeutic pipeline continues to have a strong presence of several more conventional non-specific symptomatic therapies, it also includes promising targeted biologic therapies, which points towards their increasing prominence in the therapy area, states the report.

The research report also presents a thorough assessment of the competitive landscape of the global respiratory drugs by analyzing the company profiles of the key players, keeping its focus on their performance in general, their annual turnover, current product portfolio, upcoming products, and the main strategies they have adopted for the advancement of their businesses. AstraZeneca, Boehringer Ingelheim, Merck & Co., Sumitomo Dainippon, Roche, Regeneron, Novartis, Vertex, GlaxoSmithKline, and Teva are the main market participants, mentioned in this study. Among these, GSK, Boehringer Ingelheim, and AstraZeneca have surfaced as the leading players in terms of the market share, reveals the research report.


The main objective of this market study is to present an unbiased picture of the worldwide market for respiratory drugs to the players and stakeholders in a bid to assist them in making a well-informed decision for the development of their businesses.

About Us

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Media Contact
Company Name: Researchmoz Global Pvt. Ltd.
Contact Person: Rohit Bhisey
Email: Send Email
Phone: +15186212074
Address:90 State Street
City: Albany
State: New York 12207
Country: United States

Related Articles


February 2018
« Jan